Olanzapine plus dialectical behavior therapy for women with high irritability who Meet criteria for borderline personality disorder: A double-blind, placebo-controlled pilot study

Journal of Clinical Psychiatry

Volumn 69, Issue 6, 2008, Pages 999-1005

  Linehan, Marsha M ^a,d   McDavid, Joshua P ^a   Brown, Milton Z ^b   Sayrs, Jennifer H R ^a   Gallop, Robert J ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^c WEST CHESTER UNIVERSITY   (United States)

^d Eli Lilly

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; PLACEBO;

ADJUVANT THERAPY; ADULT; AGGRESSION; ANGER; ARTICLE; AUTOMUTILATION; BEHAVIOR THERAPY; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HOSTILITY; HUMAN; IRRITABILITY; LANGUAGE; LOW DRUG DOSE; MUSCLE STIFFNESS; NERVOUSNESS; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; WEIGHT GAIN;

EID: 46749120714     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0617     Document Type: Article

References (33)

1. Fassino S, Daga GA, Piero A, et al. Dropout from brief psychotherapy in anorexia nervosa. PsychotherPsychosom 2002;71(4):200-206
2. Hellman ID, Morrison TL, Abrarnowitz SI. The stresses of psychotherapeutic work: a replication and extension. J Clin Psychol 1986; 42:197-205
3. Soloff PH, George A, Nathan S, et al. Amitiiptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989;9(4):238-246
4. Soloff PH. Is there any drag treatment of choice for the borderline patient? Acta Psychiatr Scand Suppl 1994;379:50-55
5. Beasley CM. Jr, Hamilton. SH, Crawford AM, et al. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol 1997;7(2):125-137
6. Schulz SC, Camlin KL, Berry SA, et al. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthyrnia. Biol Psychiatry 1999;46:1429-1435
7. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry .2001;62(11):849-854
8. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004; 65(7):903-907
9. Bogenschutz MP, Nurnberg GH. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 2004;65(1): 104-109
10. Soler J, Pascual JC, Campins J, et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 2005;162(6):1221-1224
11. Lieb K, Zanarini M, Linehan MM, et al. Seminar section: borderline personality disorder. Lancet 2004;364:453-461
12. Linehan MM, Comtois K A, Murray A, et, al. Two-year randomized trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006;63(7):757-766
13. Linehan MM, Armstrong HE, Suarez A, et al. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-1064
14. Koons CR, Robins CJ, Tweed J.L, et al. Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behav Therapy 2001;32:371-390
15. Loranger AW. Personality Disorder Examination (PDF.) Manual. Yonkers, NY: DV Communications; 1988
16. First MB, Spitzer RL, Gibbons M, et al. User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996
17. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, et, al. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci 1991 ;3(2): S44-S51
18. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IVAxis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995
19. Linehan MM. Skills Training Manual for Treating Borderline Personality Disorder. New York, NY: Guilford Press; 1993
20. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: Guilford Press; 1993
21. Miller IW, Bishop SB, Norman WH, et al. The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res 1985;14:131-142
22. Bryk AS, Raudenbush SW. Hierarchical Lineal: Models: Applications and Data Analysis Methods. Newbury Park, Calif: Sage; 1992
23. Littell RC, Milliken GA, Stroup WW, et al. SAS System for Mixed Models. Gary, NC: SAS Institute, Inc; 1996
24. Diggle PJ, Liang K, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 1996
25. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342(20):1462-1470
26. Hedeker D, Mermelstein RJ. Analysis of longirudinal substance use outcomes using ordinal random-effects regression models. Addiction 2000; 95(suppl 3):S381-S394
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988
28. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60(1):82-91
29. Institute of Medicine. Small Clinical Trials: Issues and Challenges. Washington, DC: National Academy Press; 2001
30. Atkins DC. Using multilevel models to analyze couple and family treatment data: basic and advanced issues. J Fam Psychol 2005; 19(1):98-110
31. Hedeker D, Gibbons RD, Waternaux C. Sample size estimation for longitudinal designs with attrition: comparing time-related contrasts between two groups. J Ed Behav Stat 1999;27(236):249
32. Raudenbush SW. Statistical analysis and optimal design for cluster randomized trials. Psychol Methods 1997;2(2):173-185
33. Raudenbush SW, Xiao-Feng L. Effects of study duration, frequency of observation, and sample size on power in studies of group differences in polynomial change. Psychol Methods 2001;6(4):387-401